Research Comparison

BPC-157 vs KPV: Two Preclinical Research Peptides Compared

BPC-157 and KPV are both studied in preclinical models related to tissue integrity. BPC-157 is a 15-amino-acid gastric peptide, while KPV is a 3-amino-acid fragment of alpha-melanocyte-stimulating hormone (α-MSH).

Property
BPC-157
KPV
Amino Acids
15
3
MW
1,419.53 Da
342.43 Da
Origin
Gastric juice protein
α-MSH C-terminal fragment
CAS
137525-51-0
67727-97-3
Research Stage
Preclinical (100+ papers)
Preclinical (limited papers)

Molecular Comparison

BPC-157 (MW 1419.53 Da, CAS 137525-51-0) is derived from human gastric juice protein BPC. Seiwerth et al. (2021, PMID: 34267654) reviewed its published preclinical research across multiple rodent tissue models.

KPV (Lys-Pro-Val, MW 342.43 Da, CAS 67727-97-3) is the C-terminal tripeptide of α-MSH. Dalmasso et al. (2008, PMID: 18061177) demonstrated NF-κB nuclear translocation inhibition in cell culture models.

Frequently Asked Questions

What is the difference between BPC-157 and KPV?+
BPC-157 is a 15-amino-acid gastric peptide (MW 1420 Da) with 100+ published papers. KPV is a 3-amino-acid α-MSH fragment (MW 342 Da) with a smaller but growing research base. They differ in size, origin, and the extent of published literature.

Research Use Only

FOR RESEARCH USE ONLY. Products sold by Healthy Aminos are intended strictly for in-vitro research and laboratory use. Not for human or animal consumption. Not FDA approved. By purchasing from Healthy Aminos, the buyer acknowledges that these products are not intended to diagnose, treat, cure, or prevent any disease. All products are sold as reference standards and research chemicals only.